Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Contineum Therapeutics in the offering, and Sidley Austin represented the underwriters. Contineum Therapeutics, a clinical stage biopharmaceutical company,...
Contineum Therapeutics’ $110 Million IPO
Capricor Therapeutics’ US$23 Million Common Stock Offering
Sidley represented Capricor Therapeutics, while Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo represented Cantor Fitzgerald in the transaction. Capricor Therapeutics, Inc. has completed the issuance and...
Akeso’s US$5 Billion Licensing Agreement With Summit Therapeutics Title
Sidley advised Akeso Inc. on the deal. Akeso Inc. announced a high-profile US$5 billion collaboration and licensing agreement with Summit Therapeutics Inc. to out-license its breakthrough bispecific...